Joshua A. Goldberg, PhD, received his BSc in Physics and PhD in computational and systems neuroscience from the Hebrew University of Jerusalem and his postdoctoral training at the University of Texas at San Antonio. He was a research assistant professor at Northwestern University before establishing an independent laboratory at the Hebrew University in 2013. Dr. Goldberg has worked on a variety of pre-clinical models of Parkinson’s disease and other movement disorders. His work has focused on the physiological mechanisms underlying neurodegeneration; and the pathophysiological adaptations that occur both in global brain dynamics and in the autonomous activity of neurons affected by these disorders.
Dr. Goldberg held a three-year position in the medical device industry heading the prototyping and ex vivo testing of a vagal nerve stimulation electrode for the CardioFitTM system for treatment of congestive heart failure, which is currently deployed in an FDA-approved Phase III clinical trial.